Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Feb-06-2024
Trade ***4225
Buy 500 Shares of NLST Limit at $1.60 (Day)
Filled at $1.593
--
Feb-06-2024
Trade ***4225
Buy 100 Shares of NLST Limit at $1.60 (Day)
Filled at $1.59
eat the DIP
gobble gobble gobble :D
ask surely looks like its thinning out!
nice vol today.. i'd say someone is confident in something happening sometime..... very soon. :D
CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced it has closed a loan facility with funds and accounts managed by BlackRock. The loan provides Akebia with up to $55.0 million of borrowing capacity available in three tranches.
At the closing, Akebia drew the first tranche of $37.0 million and used the proceeds to pay down $35.0 million of principal outstanding from a loan agreement with Pharmakon Advisors, LP (Pharmakon), the investment manager of the BioPharma Credit funds, plus interest and fees. The new agreement substantially extends the interest-only period in the event of vadadustat approval by the U.S. Food and Drug Administration (FDA) without requiring any principal repayment until December 31, 2025, with an option for Akebia to extend until December 31, 2026.
$AKBA profit taking! hope you took some off the table!
my grandmother used to type that on her typewriter all the time. instead of party she would use the word society. lol.
Hmmmmmmmm
Lafc moved back to 2.46!! Looking good here
added 2k @ .343
PDUFA explanation https://www.fool.com/terms/p/pdufa-date/
What percentage of PDUFA are approved?
Characteristic Percentage of drugs approved in 2023
Met PDUFA goal date* 89%
First cycle of review 84%
Approved in the United States before receiving approval in any other country 64%
Priority review 56%
From <https://www.google.com/search?q=pdufa+explantion&oq=pdufa+explantion&gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIGCAEQLhhA0gEINDc5MGowajGoAgCwAgA&sourceid=chrome&ie=UTF-8>
$AKBA via stocktwit @Bidzill @fresh10 fresh - We have PDUFA date scheduled for March 27, 2024 concerning Vadadustat DD USA. Approval is de-risked and highly likely, IMO. We have product launch date first half of year for Vadadustat DD EU/Australia. We have phase 2 trial for AKB 9090 for second half of 2024. We have Auryxia all time/near all time high sales 2024. Good luck 🍀 to you and us.
$NLST Smart Money is buying!
Noticed that as well on trading view
$AKBA from stocktwits
MORE GOOD NEWS - FDA Fast Track Designation is process designed to facilitate development & expedite drug review to treat serious conditions & fill UNMET MEDICAL NEED. Determining whether condition is serious enough for designation is matter of judgment … ARDS is life threatening & acute, diffuse, inflammatory form of lung injury in seriously ill patients characterized by poor oxygenation, pulmonary infiltrates, acute onset. Unadjusted hospitalization mortality was reported to be 35% among those w/ mild ARDS, 40% w/ moderate disease, 46% for patients w/ severe ARDS. AKB 9090 is Akebia’s ARDS drug. Filling an unmet need is defined as providing therapy where none exists or which may be potentially better than available therapy. Drug that receives Fast Track is eligible for accelerated approval/priority review. August of 2022, CEO Butler said Vadadustat was in trials for Covid-19/ARDS which was an “unmet medical need.” Butler was signaling intention to go after Fast Track status.
https://stocktwits.com/buythehornz127/message/559186953
John P. Butler, President and Chief Executive Officer of Akebia Therapeutics, Inc. (the “Company”), plans to present the information in the presentation attached hereto as Exhibit 99.1 (the “Presentation”) at the 42 Annual J.P. Morgan
Healthcare Conference on January 11, 2024 at 11:15 a.m. PST, which includes preliminary unaudited net product revenue for Auryxia® cumulative and for the fiscal year ended December 31, 2023. Spokespersons of the Company also plan
to present the information in the Presentation at various meetings beginning on January 8, 2024, including investor and analyst meetings that coincide with the J.P. Morgan Healthcare Conference
https://ir.akebia.com/static-files/0be66d7f-9988-43fa-bcab-e587260e1dc0
too many good things happening btw Feb and April. When shorty is forced to cover that position this is going to the MOON. imo!
the short squeeze is going to be EPIC
SOMEONE'S SELLING. IS THIS GOING BACK TO.005???????
$NLST going UP! https://schrts.co/HEWgPkpg
Dunxin Financial Holdings Limited, together with its subsidiaries, engages in the microfinance lending business in the People's Republic of China. It offers consumer, commercial, collateral-backed, and enterprise loans to micro sized enterprises, SMEs, sole proprietors, and individuals. The company is headquartered in Wuhan, China.
china bail out on the way. buckle up
https://www.economist.com/finance-and-economics/2023/11/30/china-edges-towards-a-big-bail-out
easy money https://schrts.co/JdqbEsCN wait till the real news drops!
$NLST EASY MONEY https://schrts.co/NTqnhpbV
LAFC was on the ask with a nice amount of shares. they are gone for now..
someone's selling they are filling me at 1.745
$NLST im on the bid fighting!! LOL
not yet but my bids in...
ask looks stacked. someone better hurry up and slap it! 😋
why would anyone put 50 bucks into this
$NLST i need some pics! LOL
dbl bottom off .30! looking good here!
added 2500 @ 1.90 and 300 more at 1.86!!!!! buy the DIP. FLIP THE CHIP. EASY MONEEEEE
50+? when??? Should i buy now? or will it hit a new 52 week low??
$DBGI TIMBER! https://schrts.co/rzHkaxbN
1.4 MM shares traded yesterday on the day the court issues a termination of schedule hearing. someone knows something IMO..
Hong has no choice but to stick it to them in order to set the tone. He is going after a much bigger FISH IMO (GOOGLE)
Will not close down. volume precedes price. trading 101